UiPath (PATH) Stock Drops As Profitability Holds But Growth Questions Deepen

UiPath stock just dropped 16.6% to US$15.19, wiping out recent gains in a single session. Yet the headline from this quarter is not collapse. The company posted US$410.3 million in revenue and kept non GAAP operating margin at 22%, marking a fourth straight quarter of GAAP profitability.

Short term traders are reacting to the price chart. Longer term investors are likely to focus on a software automation business that now runs at roughly US$1.9b in annual recurring revenue and continues to generate high gross margins. The rest of this report explains how that tension is shaping the UiPath story.

Is UiPath trading at a genuine discount after this drop, or does the slower forecast growth justify the lower P/E? Compare the current share price with our valuation analysis for UiPath.

Q2 2027 Earnings Summary

• Revenue (Q2 2027 vs Q2 2026): US$410.3m vs. US$361.7m (up about 13%)
• Net Income (Q2 2027 vs Q2 2026): US$36.1m vs. US$1.6m (very large increase from a near breakeven result)
• Basic EPS (Earnings Per Share) (Q2 2027 vs Q2 2026): US$0.07 vs. US$0.00 (very large increase from a near breakeven result)
• Annual Recurring Revenue (ARR, Q2 2027 vs Q2 2026): US$1.94b vs. roughly US$1.73b (up 12%)

Prefer clean charts instead of another wall of earnings tables and metrics? Get a full visual view of UiPath, including how analysts are framing its outlook and growth expectations, in our company report for UiPath.

Evaluating UiPath’s Automation And AI Bull Case

Bulls argue UiPath will prove that orchestration plus AI agents can drive durable automation demand, bigger deals and steadier recurring revenue. Q2 gives partial support. ARR reached US$1.938b with 12% growth and net new ARR of US$37m, while cloud ARR of roughly US$1.3b grew faster at more than 19%. That lines up with the idea that customers are shifting workloads to UiPath’s cloud platform rather than treating it as one off tooling.

The thesis also leans on AI heavy, regulated use cases and larger accounts. Eighteen of the top 20 deals used AI, customers with more than US$1m ARR grew 21% to 387, and dollar based net retention was 109%. Case studies like Banco Azteca’s large scale Maestro deployment and early results showing around 60% lower implementation effort with coding agents are concrete proof points that the platform is being used for complex, end to end automation rather than just simple tasks.

Reveal where the surface looks calm, but the multi year models for UiPath start to diverge, and see what the street is quietly building into revenue and margin expectations with the analyst estimates for UiPath.

UiPath Bears See Growth Ceiling, Not AI Moat

The bearish view is that UiPath is hitting a growth ceiling while generative AI eats away at its automation moat. The Q2 print gives that view some support. ARR grew 12% to US$1.938b and net new ARR was US$37m, which keeps the company on track but leaves little room for error against the target of US$124m to US$134m net new ARR in the second half. That is the key milestone bears are watching and it is not yet cleared.

Bears also worry that AI work remains stuck in pilots. Management highlighted that 18 of the top 20 deals included AI and that customers with more than US$1m ARR rose 21% to 387, so large accounts are engaging. However, guidance still points to similar ARR growth to Q1, not an obvious AI driven step up. Combined with the 16.6% share price drop, the concern about growth durability is not disproved by these results.

With UiPath now profitable and trading at a lower P/E than many software peers, the key question is whether cash generation, liabilities and reinvestment needs actually support this earnings profile. Verify the balance sheet strength, cash runway and potential dilution risk in the full financial health analysis of UiPath stock.

Take Control Of Your Next Move

If UiPath now sits on your radar after this sharp price move and conflicting growth views, register for free with Simply Wall St and add it to a Watchlist to track the share price against fair value and spot an entry that fits your plan. Once you are invested, use the Portfolio Command Center to cut through daily noise and focus on the key events that matter for your holdings. Round that out with the Community to see how other investors are thinking about UiPath and similar stocks over different time horizons. By surfacing potential catalysts and risks early, you give yourself a better chance of staying ahead of the market.

Seeking Alternatives Beyond UiPath?

Fresh ideas move fast. While the crowd chases yesterday’s breakout, you can focus on under the radar picks with real momentum before the edge drops away. Act now.

• Scan for resilient compounding potential by starting with companies on the list of solid balance sheet and fundamentals stocks (52 results) that can keep funding growth even when conditions get tougher.
• Ride the AI momentum where profits already matter by reviewing the curated list of 72 profitable AI stocks that aren't just burning cash before the strongest trends get fully priced in.
• Target powerful income streams that may hold up when growth stories cool by checking out the hand picked 11 dividend fortresses.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com